Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions
- PMID: 20118324
- PMCID: PMC2951475
Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions
Abstract
Assessment of health-related quality of life (HRQOL) using patient-reported outcomes in arthroplasty has become popular because it provides a unique perspective on successful elective procedures. However, challenges exist in the assessment of HRQOL in clinical practice and in clinical research. Patient compliance with multiple and sometimes lengthy HRQOL assessments administered at multiple follow-up visits is problematic. Many well-validated HRQOL instruments are available, and progress has been made in defining the minimal clinically important difference in hip and knee arthroplasty that denotes the minimal change perceived to be important by patients. Challenges in understanding the literature are attributable to the use of various HRQOL scales, with different scoring ranges and scoring algorithms, different interpretations of highest score, and differences in the presentation of raw versus transformed scores.
Figures

References
-
- Ethgen O, Bruyère O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty: A qualitative and systematic review of the literature. J Bone Joint Surg Am. 2004;86:963–974. - PubMed
-
- Kane RL, Saleh KJ, Wilt TJ, Bershadsky B. The functional outcomes of total knee arthroplasty. J Bone Joint Surg Am. 2005;87:1719–1724. - PubMed
-
- Sloan J. Applying QOL assessments: Solutions for oncology clinical practice and research. Part 1. Curr Probl Cancer. 2005;29:271–351.
-
- Sloan JA, Cella D, Frost M, et al. Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc. 2002;77:367–370. - PubMed
-
- Huschka MM, Mandrekar SJ, Schaefer PL, Jett JR, Sloan JA. A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer. 2007;109:787–795. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical